Syndicate content

"Zone in with Zon" at Boston TIDES Conference

Dr. Gerald Zon’s latest blog post in “Zone in with Zon—What’s Trending in Nucleic Acid Research,” (http://zon.trilinkbiotech.com/) was posted on June 3, 2013, and it features a report on the 15th Anniversary TIDES (Oligonucleotide and Peptide Therapeutics from Research through Commercialization) 2013 conference in Boston. Dr. Zon’s post is entitled, “Nucleic Acids Are Getting Small, SMARTT, Long, and Weird." Unable to attend in person, Dr. Zon relied on an on-site report from TriLink President/CEO Rick Hogrefe, Ph.D., to provide the raw material for his commentary. Among the topics covered were spherical nucleic acids and nanoparticle delivery as discussed by Professor Chad A. Murkin of Northwestern University and founder of AuraSense; block-polymer delivery as discussed by Dr. Mary Prieve of PhaseRx; targeting long non-coding RNA as described by Dr. Jim Barsum, previously with Biogen Synta, and now with Theracrine; and unnatural base pairs as discussed by Dr. Ichiro Hirao of RIKEN and President/CEO of TAGCyx Biotechnologies. Dr. Zon is an eminent nucleic acid chemist and Director of Business Development at TriLink BioTechnologies in San Diego, California. [Zon blog post] [TIDES web site]